Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 69 Multiple Myeloma 44 Precursor Cell Lymphoblastic Leukemia-Lymphoma 42 Myelodysplastic Syndromes 37 Lymphoma 37 Leukemia, Lymphocytic, Chronic, B-Cell 37 Lymphoma, Non-Hodgkin 33 Leukemia 32 Recurrence 31 Lymphoma, B-Cell 30 Melanoma 27 Lymphoma, Large B-Cell, Diffuse 22 Ovarian Neoplasms 17 Lymphoma, Mantle-Cell 17 Lymphoma, Follicular 16 Hematologic Neoplasms 16 Carcinoma, Non-Small-Cell Lung 16 Burkitt Lymphoma 16 Neoplasms 15 Lymphoma, B-Cell, Marginal Zone 13 Hodgkin Disease 13 Carcinoma, Renal Cell 12 Head and Neck Neoplasms 11 Neuroblastoma 10 Leukemia, Biphenotypic, Acute 10 Graft vs Host Disease 10 Neoplasms, Plasma Cell 9 Neoplasm Metastasis 9 Colorectal Neoplasms 9 Breast Neoplasms 9

Interventions

vandetanib 2 cabozantinib 2 Trastuzumab 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 veliparib 1 vatalanib 1 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tipifarnib 1 temsirolimus 1 sargramostim 1 pentetreotide 1 mercaptoundecahydrododecaborate 1 gallium Ga 68 dotatate 1 fludarabine 1 cixutumumab 1 Vinorelbine 1 Temozolomide 1 Specimen Handling 1 Sirolimus 1 Semaxinib 1 Salts 1 Ranitidine 1 Paclitaxel 1 Omeprazole 1 Octreotide 1 Nivolumab 1 Interleukin-12 Subunit p35 1 Interleukin-12 1 High-Energy Shock Waves 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Carcinoma, Medullary × fludarabine × Clear all

NCT04877613 2025-07-03

GFRα4 CAR T Cells in MTC Patients

University of Pennsylvania

Phase 1 Active not recruiting

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡